Cargando…
Incidence of pocket hematoma after electrophysiological device placement: dual antiplatelet therapy versus low-molecular-weight heparin regimen
BACKGROUND: Given the increasing number of patients who require dual antiplatelet (DAP) therapy and electrophysiological device (EPD) placement, perioperative antiplatelet management is a current challenge. In this study, we investigated the incidence of pocket hematoma formation after EPD placement...
Autores principales: | Chen, Yan, Li, Yun-Tao, Gao, Ming-Dong, Zeng, Ze-Chun, Zhang, Jin-Rong, Cong, Hong-Liang, Liu, Yin, Zhao, Ru, Wang, Le-Feng, Yang, Xin-Cun, Meng, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178510/ https://www.ncbi.nlm.nih.gov/pubmed/25278967 http://dx.doi.org/10.11909/j.issn.1671-5411.2014.03.013 |
Ejemplares similares
-
Dual antiplatelet therapy increases pocket hematoma complications in Chinese patients with pacemaker implantation
por: Dai, Yan, et al.
Publicado: (2015) -
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
por: Taleja, Hitesh, et al.
Publicado: (2021) -
Urokinase Salvage Therapy for Recurrent Chronic Subdural Hematoma Caused by Dual Antiplatelet Therapy
por: Bao, Jing, et al.
Publicado: (2023) -
Chronic Expanding Hematoma in Device Pocket Developing 5 Years After Implantation
por: Uchida, Tomoyuki, et al.
Publicado: (2023) -
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
por: Sottilotta, Gianluca, et al.
Publicado: (2021)